2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Maria I. Florez
Advertisement
Articles by Maria I. Florez
The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
2025 SCRS Global Site Solutions Summit: How to Streamline Site Qualification and Initiation Training
4
AI Everywhere: Architecting the Future of Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
